2024: Fannin Innovation Studio Accepted Into NIDA's Medications Discovery Program
Previous
Previous
2024: Fannin Partners Secures Grant Funding from NIDA and DoD to Advance Novel PDE4B Inhibitors for Neurological Diseases
Next
Next